N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression

(2023) Peng Xia et al.   Cancer Communications

The role of m6A RNA methylation in cancer metabolism

(2022) Yuanyuan An et al.   Molecular Cancer

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA

(2022) Zhangjin Shen et al.   ONCOGENE

The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance

(2021) Qing Lan et al.   CANCER RESEARCH

Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target

(2021) Frankis A. Almaguel et al.   Frontiers in Genetics

N6-methyladenosine (m6A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer

(2021) Jun Tang et al.   Cell Death Discovery

Ovarian Cancer Immunotherapy and Personalized Medicine

(2021) Susan Morand et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma

(2021) Peng Xia et al.   Cell Death & Disease

N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer

(2021) Senxu Lu et al.   Journal of Hematology & Oncology

Targeting cancer metabolism in the era of precision oncology

(2021) Zachary E. Stine et al.   NATURE REVIEWS DRUG DISCOVERY

Therapeutic targeting of SPIB / SPI1 ‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression

(2021) Jianqun Wang et al.   Clinical and Translational Medicine

METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST

(2020) Xiao Yang et al.   Molecular Cancer

The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation

(2020) Tao Liu et al.   NUCLEIC ACIDS RESEARCH

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

(2020) Xingya Guo et al.   Molecular Cancer

The potential role of RNA N6-methyladenosine in Cancer progression

(2020) Tianyi Wang et al.   Molecular Cancer

Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression

(2020) Mei-lin Weng et al.   Nature Communications

Mechanism of RNA modification N6-methyladenosine in human cancer

(2020) Zijian Zhou et al.   Molecular Cancer

SPI1-induced upregulation of lncRNA SNHG6 promotes non-small cell lung cancer via miR-485-3p/VPS45 axis

(2020) Nan Gao et al.   BIOMEDICINE & PHARMACOTHERAPY

METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway

(2020) Xuehan Bi et al.   CANCER GENE THERAPY

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

(2020) Chang Yang et al.   Frontiers in Immunology

Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)

(2020) Hui Fan et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications

(2020) Lidong Cao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A

(2020) Wenhua Zhao et al.   PATHOLOGY RESEARCH AND PRACTICE

CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway

(2020) Guanqun Huang et al.   Cell Death & Disease

Nanotechnology in ovarian cancer: Diagnosis and treatment

(2020) Mahmood Barani et al.   LIFE SCIENCES

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA

(2019) Xiaoyu Cheng et al.   OncoTargets and Therapy

METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner

(2019) Jie Han et al.   Molecular Cancer

The enhancement of glycolysis regulates pancreatic cancer metastasis

(2019) Jinshou Yang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Reading, writing and erasing mRNA methylation

(2019) Sara Zaccara et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Long noncoding RNA SNHG16 promotes the tumorigenicity of cervical cancer cells by recruiting transcriptional factor SPI1 to upregulate PARP9

(2019) Ling Tao et al.   CELL BIOLOGY INTERNATIONAL

CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1

(2019) Jiayu Zhou et al.   Cell Death & Disease

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3

(2019) Tian Lan et al.   Molecular Cancer

Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation

(2018) Huilin Huang et al.   NATURE CELL BIOLOGY

Alpha-Enolase i ENO1 i a potential target in novel immunotherapies

(2017) Francesco Novelli   Frontiers in Bioscience-Landmark

Nuclear m 6 A Reader YTHDC1 Regulates mRNA Splicing

(2016) Wen Xiao et al.   MOLECULAR CELL

Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ Sites

(2014) Schraga Schwartz et al.   Cell Reports

Cancer Cell Metabolism: Warburg and Beyond

(2008) Peggy P. Hsu et al.   CELL